Overview | General Toxicology | Carcinogenicity
Developmental & Reproductive Toxicology
Immunotoxicology | Pharmacokinetics & Biodistribution
Safety & efficacy Models | Safety Pharmacology
Archiving

Safety & Efficacy Models

Many disease models have gained attention in recent years as the search for ways to improve quality of life has intensified. SNBL USA provides the following disease models to our clients:

Human Immunodeficiency Virus (HIV)

• Primate-adapted human immunodeficiency virus type 2 (HIV-2)
• Conducted in compliance with FDA Good Laboratory Practice (GLP) regulations for Nonclinical Laboratory Studies (21 CFR Part 58)
• Immune Assessments [Immunophenotyping, Functionality Testing]

Future offerings of additional NHP models for Infectious Disease include:

Simian Human Immunodeficiency Virus (SHIV)
Poliomelitis (Polio)
Simian Retrovirus (SRV)
Human T-cell Lymphotropic Virus (HTLV)
Simian T-cell Lymphotropic Virus (STLV)

Osteoporosis

• Performed in aged females
• Quantitative Computed Tomography (pQCT) and Dual Energy X-ray Absorptometry (DEXA) analysis of bone mineral density and content
• Histomorphemetry
• Conducted in compliance with FDA Good Laboratory Practice (GLP) regulations for Nonclinical Laboratory Studies (21 CFR Part 58